August 21, 2011 – DHR International has placed Robin Stracey as a member of the board of directors at ThermoGenesis Corporation. Executive vice president, managing director and global life sciences practice leader John Baker led the search for DHR with assistance from J.L. Baker, principal, life sciences practice. Mr. Stracey currently serves as chairman, president and chief executive officer of Cantimer. ThermoGenesis is a leader in developing and manufacturing automated blood processing systems and disposable products that enable the manufacture, preservation and delivery of cell and tissue therapy products. Founded in 1989, DHR International is headquartered in Chicago and has more than 50 offices worldwide.